We are live on ! Find out more
AHG

Akso Health Group

12 hedge funds and large institutions have $4.39M invested in Akso Health Group in 2019 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 2 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

250% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 2

0.16% less ownership

Funds ownership: 1.41%1.25% (-0.16%)

8% less funds holding

Funds holding: 1312 (-1)

25% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 4

37% less capital invested

Capital invested by funds: $6.93M → $4.39M (-$2.53M)

Holders
12
Holders Change
-1
Holders Change %
-7.69%
% of All Funds
0.26%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
7
Reduced
2
Closed
4
Calls
Puts
Net Calls
Net Calls Change

AHG Hedge Fund Activity: Q2 2019 in Review

12 of the 4,624 institutional investors tracked by Wall St. Rank reported a position in Akso Health Group (AHG) for Q2 2019, worth a combined $4.39M — down 37% from $6.93M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of AHG and 3 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 7 added.

The largest buyer was Mackenzie Financial, adding an estimated $365K. The largest seller was AJO LP, cutting an estimated $1.53M.

  • 12 institutional investors held Akso Health Group (AHG) as of Q2 2019, down from 13 in Q1 2019.
  • Funds reported $4.39M of Akso Health Group stock for Q2 2019, down 37% quarter-over-quarter.
  • 3 funds opened new Akso Health Group positions in Q2 2019 and 4 closed out, a net change of -1 holder.
  • The largest Akso Health Group buyer in Q2 2019 was Mackenzie Financial, an estimated $365K added.
  • The largest Akso Health Group seller in Q2 2019 was AJO LP, an estimated $1.53M sold.

Based on aggregated 13F filings for Q2 2019.